Results 51 to 60 of about 39,748 (262)
Bipartite Consensus Problems on Second-Order Signed Networks With Heterogeneous Topologies
This paper is devoted to the convergence problem for second-order signed networks that are associated with two signed graphs in the presence of heterogeneous topologies.
Jianheng Ling +2 more
doaj +1 more source
On composition of signed graphs
A graph whose edges are labeled either as positive or negative is called a signed graph. In this article, we extend the notion of composition of (unsigned) graphs (also called lexicographic product) to signed graphs. We employ Kronecker product of matrices to express the adjacency matrix of this product of two signed graphs and hence find its ...
K. Augustine Germina +1 more
openaire +1 more source
Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic +5 more
wiley +1 more source
Signed Complete Graphs with Maximum Index
Let Γ = (G, σ) be a signed graph, where G is the underlying simple graph and σ E(G) → {−, +} is the sign function on the edges of G. The adjacency matrix of a signed graph has −1 or +1 for adjacent vertices, depending on the sign of the edges.
Akbari Saieed +3 more
doaj +1 more source
Matroids of Gain Signed Graphs
13 fig., 46 pp. v2 has new Example 3.7, minor editing, 47 pp.
Laura Anderson +2 more
openaire +2 more sources
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric +10 more
wiley +1 more source
On Cartesian Products of Signed Graphs [PDF]
In this paper, we study the Cartesian product of signed graphs as defined by Germina, Hameed and Zaslavsky (2011). Here we focus on its algebraic properties and look at the chromatic number of some Cartesian products. One of our main results is the unicity of the prime factor decomposition of signed graphs.
openaire +2 more sources
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera +11 more
wiley +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
On the Powers of Signed Graphs
A signed graph is an ordered pair $Σ=(G,σ),$ where $G=(V,E)$ is the underlying graph of $Σ$ with a signature function $σ:E\rightarrow \{1,-1\}$. In this article, we define $n^{th}$ power of a signed graph and discuss some properties of these powers of signed graphs.
T V, Shijin, K A, Germina, K, Shahul
openaire +2 more sources

